North America Pharmaceutical Drug Delivery Market Segments and Growth by 2027

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027

North America Pharmaceutical Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By  Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery); Application (Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory. Diseases, Central Nervous System Disorders, Autoimmune Diseases, and Other Diseases); End User (Hospitals, Home Care Settings, ASC/Clinics, Other End Users); and Country

  • Report Date : Jun 2020
  • Report Code : TIPRE00011595
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 145

The North America pharmaceutical drug delivery market is anticipated to reach US$ 936,148.9 Mn by 2027 from US$ 560,491.5 Mn in 2019. The market is projected to grow at a CAGR of 6.8% during 2020–2027.



The growth of the market in this region is primarily ascribed to the increasing prevalence of chronic diseases. On the other hand, the high cost of developing drug delivery devices hinders the market growth. On the other hand, increasing spending in the R&D related to drug delivery devices is expected to fuel the growth of the North American pharmaceutical drug delivery market in the coming years. Pharmaceutical and medical devices companies are focusing on R&D to develop new molecules for various therapeutic applications and drug delivery platforms. They invest majorly on R&Ds with an aim to deliver high-quality and innovative products. R&D spending by the biopharmaceutical companies has also increased over the years. According to a report of Pharmaceutical Research and Manufacturers of America (PhRMA), the R&D expenditure of the biopharmaceutical companies increased from US$ 49.6 billion 2012 to US$ 58.8 billion in 2015. Evonik Corporation has invested more than US$ 50 million over the last 4 years to advance its competencies in the medical devices market as well as in the marketplace for RESOMER polymers for drug delivery and bioreabsorbable medical devices.

Additionally, the companies are engaged in establishing new collaborations and partnerships for the development of new drug delivery systems. For instance, in December 2018, IntelGenx Corp., a leading oral drug delivery company, entered into a strategic collaboration with Gensco Pharma for the commercialization of RIZAPORT in the US. The newly approved device would be the first oral thin film to be used in the treatment of migraines. In April 2020, Revive Therapeutics announced research partnership with the University of Wisconsin-Madison to develop novel formulations and drug delivery technologies.

In 2019, the US accounted for the largest share in North America pharmaceutical drug delivery market, and it is also expected to grow at a faster pace over the forecast period. The US is an economically advanced country, and it leverages the presence of various well-established pharmaceutical market players. Increasing prevalence of chronic diseases such as diabetes and asthma, growing number of product launches by key players, and increasing use of drug delivery devices for disease management are among the key factors driving the country toward the largest market share.


US Pharmaceutical Drug Delivery Market, Revenue and Forecast to 2027 (US$ Mn)

US Pharmaceutical Drug Delivery Market
  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

NORTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET SEGMENTATION

By Route of Administration

  • Oral Drug Delivery
  • Injectable Drug Delivery
  • Topical Drug Delivery
  • Ocular Drug Delivery
  • Pulmonary Drug Delivery
  • Nasal Drug Delivery
  • Transmucosal Drug Delivery
  • Implantable Drug Delivery

By Application

  • Infectious Diseases
  • Cancer
  • Cardiovascular Diseases
  • Diabetes
  • Respiratory Diseases
  • Central Nervous System Disorders
  • Autoimmune Diseases
  • Other Applications

By End User

  • Hospitals
  • Home Care Settings
  • ASC/Clinics
  • Other End Users

By Country

  • North America

    • US
    • Canada
    • Mexico

Company Profiles

  • 3M
  • Antares Pharma
  • BD
  • Pfizer Inc.
  • Johnson & Johnson Services, Inc.

North America Pharmaceutical Drug Delivery Report Scope

Report Attribute Details
Market size in 2019 US$ 560,491.5 Million
Market Size by 2027 US$ 936,148.9 Million
Global CAGR (2020 - 2027) 6.8%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Route of Administration
  • Oral Drug Delivery
  • Injectable Drug Delivery
  • Topical Drug Delivery
  • Ocular Drug Delivery
  • Pulmonary Drug Delivery
  • Nasal Drug Delivery
  • Transmucosal Drug Delivery
  • Implantable Drug Delivery
By Application
  • Infectious Diseases
  • Cancer
  • Cardiovascular Diseases
  • Diabetes
  • Respiratory. Diseases
  • Central Nervous System Disorders
  • Autoimmune Diseases
  • Other Diseases
By End User
  • Hospitals
  • Home Care Settings
  • ASC/Clinics
  • Other End Users
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Market leaders and key company profiles
  • 3M
  • Antares Pharma
  • BD
  • Pfizer Inc.
  • Johnson & Johnson Services, Inc.
  • Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Identifying Emerging Markets
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Boosting Operational Efficiency
    • Strategic Planning
    • Investment Justification
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients

    The List of Companies - North America Pharmaceutical Drug Delivery Market

    1. 3M
    2. Antares Pharma
    3. BD
    4. Pfizer Inc.
    5. Johnson & Johnson Services, Inc.
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo